Підписатись
Elio Gregory Pizzutilo
Elio Gregory Pizzutilo
Università degli Studi di Milano, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda
Підтверджена електронна адреса в ospedaleniguarda.it
Назва
Посилання
Посилання
Рік
Association of steroids use with survival in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
F Petrelli, D Signorelli, M Ghidini, A Ghidini, EG Pizzutilo, L Ruggieri, ...
Cancers 12 (3), 546, 2020
2162020
Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer
A Amatu, A Sartore-Bianchi, K Bencardino, EG Pizzutilo, F Tosi, S Siena
Annals of Oncology 30, viii5-viii15, 2019
2162019
First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status
F Facchinetti, G Mazzaschi, F Barbieri, F Passiglia, F Mazzoni, R Berardi, ...
European Journal of Cancer 130, 155-167, 2020
1112020
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies
G Mauri, EG Pizzutilo, A Amatu, K Bencardino, L Palmeri, EF Bonazzina, ...
Cancer treatment reviews 73, 41-53, 2019
852019
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world …
L Cantini, G Mentrasti, GL Russo, D Signorelli, G Pasello, E Rijavec, ...
ESMO open 7 (2), 100406, 2022
482022
Liquid biopsy for rectal cancer: A systematic review
D Massihnia, EG Pizzutilo, A Amatu, F Tosi, S Ghezzi, K Bencardino, ...
Cancer treatment reviews 79, 101893, 2019
352019
High circulating methylated DNA is a negative predictive and prognostic marker in metastatic colorectal cancer patients treated with regorafenib
A Amatu, M Schirripa, F Tosi, S Lonardi, K Bencardino, E Bonazzina, ...
Frontiers in oncology 9, 622, 2019
342019
Entrectinib for the treatment of metastatic NSCLC: safety and efficacy
A Sartore-Bianchi, EG Pizzutilo, G Marrapese, F Tosi, G Cerea, S Siena
Expert Review of Anticancer Therapy 20 (5), 333-341, 2020
312020
Efficacy and safety of anti-PD-1 immunotherapy in patients aged≥ 75 years with non–small-cell lung cancer (NSCLC): an Italian, multicenter, retrospective study
A Luciani, A Marra, L Toschi, D Cortinovis, S Fava, V Filipazzi, A Tuzi, ...
Clinical Lung Cancer 21 (6), e567-e571, 2020
252020
Pneumatosis intestinalis induced by anticancer treatment: a systematic review
G Gazzaniga, F Villa, F Tosi, EG Pizzutilo, S Colla, S D’Onghia, ...
Cancers 14 (7), 1666, 2022
212022
Liquid biopsy for small cell lung cancer either de novo or transformed: systematic review of different applications and meta-analysis
EG Pizzutilo, M Pedrani, A Amatu, L Ruggieri, C Lauricella, SM Veronese, ...
Cancers 13 (9), 2265, 2021
152021
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: the multicenter retrospective CLARITY study
M Bersanelli, S Buti, D Giannarelli, A Leonetti, A Cortellini, GL Russo, ...
Lung Cancer 150, 123-131, 2020
152020
Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
G Metro, D Signorelli, EG Pizzutilo, L Giannetta, G Cerea, M Garaffa, ...
Human Vaccines & Immunotherapeutics 17 (9), 2972-2980, 2021
122021
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review
C Vaghi, G Mauri, AG Agostara, G Patelli, EG Pizzutilo, Y Nakamura, ...
Cancer Treatment Reviews 112, 102488, 2023
92023
Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a …
L Cantini, G Mentrasti, GL Russo, D Signorelli, G Pasello, E Rijavec, ...
ESMO open 7 (2), 2022
72022
Application of histology-agnostic treatments in metastatic colorectal cancer
A Sartore-Bianchi, AG Agostara, G Patelli, G Mauri, EG Pizzutilo, S Siena
Digestive and Liver Disease 54 (10), 1291-1303, 2022
62022
996P Activity of OsimeRTInib in NSCLC with UNcommon EGFR Mutations: Retrospective observational multicenter study (ARTICUNO)
EG Pizzutilo, G Cerea, S Oresti, AG Agostara, D Signorelli, S Stabile, ...
Annals of Oncology 33, S1009, 2022
52022
A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study
G Bogani, M Cinquini, D Signorelli, EG Pizzutilo, R Romanò, M Bersanelli, ...
Critical Reviews in Oncology/Hematology 187, 104016, 2023
42023
Circulating tumor DNA to drive treatment in metastatic colorectal cancer
G Patelli, G Mauri, F Tosi, A Amatu, K Bencardino, E Bonazzina, ...
Clinical Cancer Research 29 (22), 4530-4539, 2023
32023
Moving immune checkpoint inhibitors to early non-small cell lung cancer: a narrative review
G Viscardi, F Vitiello, A Servetto, V Gristina, EG Pizzutilo, MA Canciello, ...
Cancers 14 (23), 5810, 2022
32022
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20